Hailshadow/iStock via Getty Images
- GSK (NYSE:GSK) has entered into a collaboration with the UK Dementia Research Institute and Health Data Research UK to determine if the drugmaker’s shingles vaccine can lower the risk of dementia.
- GSK noted that several retrospective observational studies have found
